Novo CEO seeks partnership with generic drug makers
Novo Nordisk executive Mike Doustdar is calling for collaboration with American “compounders” that have sold imitations of the company’s weight-loss medication. Doustdar suggests these platforms deliver original, safe products to expand patient access now that supply shortages have ended. While U.S. law permits copies during shortages, Novo Nordisk claims sales persist under the guise of […]